<VariationArchive VariationID="2412680" VariationName="NM_030632.3(ASXL3):c.902_911del (p.Arg301fs)" VariationType="Deletion" Accession="VCV002412680" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2023-02-08" MostRecentSubmission="2023-02-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2401410" VariationID="2412680">
      <GeneList>
        <Gene Symbol="ASXL3" FullName="ASXL transcriptional regulator 3" GeneID="80816" HGNC_ID="HGNC:29357" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>18q12.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="33578219" stop="33751195" display_start="33578219" display_stop="33751195" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="31158540" stop="31327398" display_start="31158540" display_stop="31327398" Strand="+" />
          </Location>
          <OMIM>615115</OMIM>
          <Haploinsufficiency last_evaluated="2017-11-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ASXL3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-11-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ASXL3">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_030632.3(ASXL3):c.902_911del (p.Arg301fs)</Name>
      <CanonicalSPDI>NC_000018.10:33731986:TACGCCTCAGTAC:TAC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>18q12.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="33731987" stop="33731996" display_start="33731987" display_stop="33731996" variantLength="10" positionVCF="33731986" referenceAlleleVCF="TTACGCCTCAG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="31311951" stop="31311960" display_start="31311951" display_stop="31311960" variantLength="10" positionVCF="31311950" referenceAlleleVCF="TTACGCCTCAG" alternateAlleleVCF="T" />
      </Location>
      <OtherNameList>
        <Name>NM_030632.3:c.902_911del</Name>
      </OtherNameList>
      <ProteinChange>R301fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.10" sequenceAccession="NC_000018" sequenceVersion="10" change="g.33731990_33731999del" Assembly="GRCh38">
            <Expression>NC_000018.10:g.33731990_33731999del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.9" sequenceAccession="NC_000018" sequenceVersion="9" change="g.31311954_31311963del" Assembly="GRCh37">
            <Expression>NC_000018.9:g.31311954_31311963del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_055244.1" sequenceAccession="NG_055244" sequenceVersion="1" change="g.158414_158423del">
            <Expression>NG_055244.1:g.158414_158423del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_030632.3" sequenceAccession="NM_030632" sequenceVersion="3" change="c.902_911del" MANESelect="true">
            <Expression>NM_030632.3:c.902_911del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_085135.1" sequenceAccession="NP_085135" sequenceVersion="1" change="p.Arg301fs">
            <Expression>NP_085135.1:p.Arg301fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_030632.3(ASXL3):c.902_911del (p.Arg301fs) AND Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome" Accession="RCV002789968" Version="3">
        <ClassifiedConditionList TraitSetID="12061">
          <ClassifiedCondition DB="MedGen" ID="C4750837">Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-01-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-01-24" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2023-02-07">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="12061" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18330" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Bainbridge-Ropers syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome</ElementValue>
                <XRef ID="MONDO:0014205" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BRPS</ElementValue>
                <XRef Type="MIM" ID="615485" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13259" />
                <XRef ID="13259" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">ASXL3-related disorder is characterized by developmental delay or intellectual disability, typically in the moderate to severe range, with speech and language delay and/or absent speech. Affected individuals may also display autistic features. There may be issues with feeding. While dysmorphic facial features have been described, they are typically nonspecific. Affected individuals may also have hypotonia that can transition to spasticity resulting in unusual posture with flexion contractions of the elbows, wrists, and fingers. Other findings may include poor postnatal growth, strabismus, seizures, sleep disturbance, and dental anomalies.</Attribute>
                <XRef ID="NBK563693" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">ASXL3-Related Disorder</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33151654</ID>
                <ID Source="BookShelf">NBK563693</ID>
              </Citation>
              <XRef ID="352577" DB="Orphanet" />
              <XRef ID="C4750837" DB="MedGen" />
              <XRef ID="MONDO:0014205" DB="MONDO" />
              <XRef Type="MIM" ID="615485" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="6450393" SubmissionDate="2023-01-27" DateLastUpdated="2023-02-07" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="01e40724-b44e-454b-84bc-79f83d7373b0" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003761215" DateUpdated="2023-02-07" DateCreated="2023-02-07" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The heterozygous p.Arg301LeufsTer4 variant in ASXL3 was identified by our study in two siblings with poor growth and neurodevelopmental delay. Familial genome analysis showed this variant to be de novo. The p.Arg301LeufsTer4 variant in ASXL3 has not been previously reported in individuals with Bainbridge-Ropers syndrome. This variant was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein‚Äôs amino acid sequence beginning at position 301 and leads to a premature termination codon 4 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Heterozygous loss of function of the ASXL3 gene is an established disease mechanism in Bainbridge-Ropers syndrome. In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant Bainbridge-Ropers syndrome. ACMG/AMP Criteria applied: PVS1, PS2_Supporting, PM2_Supporting (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASXL3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_030632.3:c.902_911del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000018.10:g.33731990_33731999del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0014205" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12627697</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6450393" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0014205" MappingRef="MONDO">
        <MedGen CUI="C4750837" Name="Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

